CALCIMAR Drug Patent Profile
✉ Email this page to a colleague
When do Calcimar patents expire, and what generic alternatives are available?
Calcimar is a drug marketed by Sanofi Aventis Us and is included in two NDAs.
The generic ingredient in CALCIMAR is calcitonin salmon. There are fourteen drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the calcitonin salmon profile page.
Summary for CALCIMAR
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 30 |
Patent Applications: | 293 |
Formulation / Manufacturing: | see details |
DailyMed Link: | CALCIMAR at DailyMed |
US Patents and Regulatory Information for CALCIMAR
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sanofi Aventis Us | CALCIMAR | calcitonin salmon | INJECTABLE;INJECTION | 017769-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Sanofi Aventis Us | CALCIMAR | calcitonin salmon | INJECTABLE;INJECTION | 017497-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |